Phase I trial of AVN-101 for treatment of Alzheimer's disease.

Trial Profile

Phase I trial of AVN-101 for treatment of Alzheimer's disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jan 2010

At a glance

  • Drugs AVN 101 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Avineuro Pharmaceuticals
  • Most Recent Events

    • 01 Jan 2010 Results will be presented at ICAD 2010 in July, according to an Avineuro Pharmaceuticals media release.
    • 03 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top